/
409406007 Bevacizumab
409406007 Bevacizumab
Summary
- Status: Active
- Version: 20220731
- Last Changed: 2022-07-31
- definitionStatusId: 900000000000074008 | Primitive
- module: 999991001000101 | IPS terminology module
Text Definitions
NoneDescriptions
Suggest Synonym- Bevacizumab (substance) [ 900000000000003001 Fully specified name en,
en_GB
]
- Bevacizumab [ 900000000000013009 Synonym en,
en_GB
]
Parent Concepts
- 372688009 Antineoplastic agent
- 68498002 Antibody
- 766739005 Substance categorized by disposition
Child Concepts
Suggest Child ConceptDefining Attributes
Refsets
NoneMapsets
NoneDiagram
Browser Links
- West Coast Informatics Browser - https://ips.terminology.tools/terminology-ui/index.html#/terminology?terminology=SNOMEDCT&code=409406007#content
- SNOMED IPS Browser - https://ips-browser.ihtsdotools.org/?perspective=full&conceptId1=409406007&edition=MAIN/2022-07-31
JSON Document
{ "conceptId": "409406007", "fsn": { "term": "Bevacizumab (substance)", "lang": "en" }, "active": true, "effectiveTime": "20220731", "definitionStatus": "PRIMITIVE", "descriptions": [ { "active": true, "term": "Bevacizumab (substance)", "typeId": "900000000000003001", "acceptabilityMap": { "900000000000508004": "Preferred (foundation metadata concept)", "900000000000509007": "Preferred (foundation metadata concept)" } } ], "relationships": [ { "active": true, "typeId": "116680003", "type": { "conceptId": "116680003", "fsn": { "term": "Is a (attribute)" } }, "target": { "conceptId": "372688009", "active": true, "definitionStatus": "PRIMITIVE", "fsn": { "term": "Antineoplastic agent (substance)" } }, "groupId": 0 }, { "active": true, "typeId": "116680003", "type": { "conceptId": "116680003", "fsn": { "term": "Is a (attribute)" } }, "target": { "conceptId": "68498002", "active": true, "definitionStatus": "PRIMITIVE", "fsn": { "term": "Antibody (substance)" } }, "groupId": 0 }, { "active": true, "typeId": "116680003", "type": { "conceptId": "116680003", "fsn": { "term": "Is a (attribute)" } }, "target": { "conceptId": "766739005", "active": true, "definitionStatus": "FULLY_DEFINED", "fsn": { "term": "Substance categorized by disposition (substance)" } }, "groupId": 0 }, { "active": true, "typeId": "726542003", "type": { "conceptId": "726542003", "fsn": { "term": "Has disposition (attribute)" } }, "target": { "conceptId": "726711005", "active": true, "definitionStatus": "PRIMITIVE", "fsn": { "term": "Disposition (disposition)" } }, "groupId": 0 } ] }
, multiple selections available,
Related content
774850001 Bevacizumab only product
774850001 Bevacizumab only product
More like this
781788003 Bevacizumab 25 mg/mL solution for injection
781788003 Bevacizumab 25 mg/mL solution for injection
More like this
387003001 Trastuzumab
387003001 Trastuzumab
More like this
407317001 Adalimumab
407317001 Adalimumab
More like this
442435002 Golimumab
442435002 Golimumab
More like this
407097007 Bortezomib
407097007 Bortezomib
More like this